Adage Capital Partners
CCXI

Adage Capital Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Adage Capital Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-350,000
Closed -$14.1M – 814
2020
Q1 		$14.1M Buy
350,000
+50,000
+17% +$2.12M 0.04% 398
2019
Q4 		$11.9M Buy
+300,000
New +$5.27M 0.03% 509

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Adage Capital Partners's CCXI Position: Q2 2020 in Review

Adage Capital Partners sold out of ChemoCentryx, Inc. (CCXI) in Q2 2020, closing a stake of 350,000 shares — an estimated $14.1M sold.

Adage Capital Partners first reported a position in CCXI in Q4 2019 and held it in 2 quarters. The position peaked at $14.1M in Q1 2020. 193 funds tracked by Wall St. Rank hold CCXI as of Q2 2020.

  • Adage Capital Partners reported no remaining ChemoCentryx, Inc. position as of Q2 2020 after selling out during the quarter.
  • Adage Capital Partners sold 350,000 ChemoCentryx, Inc. shares in Q2 2020, an estimated $14.1M.
  • Adage Capital Partners first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 2 quarters.
  • Adage Capital Partners's ChemoCentryx, Inc. position peaked at $14.1M in Q1 2020.
  • 193 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2020.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.